We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.17B
AUM Growth
+$164M
Cap. Flow
+$157M
Cap. Flow %
13.37%
Top 10 Hldgs %
25.72%
Holding
3,876
New
301
Increased
2,412
Reduced
769
Closed
99

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.19M
2
NVDA icon
NVIDIA
NVDA
+$5.82M
3
MSFT icon
Microsoft
MSFT
+$5.63M
4
AMZN icon
Amazon
AMZN
+$4.37M
5
TSLA icon
Tesla
TSLA
+$3.01M

Sector Composition

Rank Sector Weight
1 Technology 24.89%
2 Financials 12.52%
3 Consumer Discretionary 8.81%
4 Healthcare 7.95%
5 Industrials 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMBC icon
2001
Embecta
EMBC
$296M
$18.6K ﹤0.01%
901
+220
+32% +$3.6K
XP icon
2002
XP
XP
$8.37B
$18.6K ﹤0.01%
1,569
+146
+10% +$2.3K
ACLX
2003
DELISTED
Arcellx
ACLX
$18.6K ﹤0.01%
242
+10
+4% +$864
MATW icon
2004
Matthews International
MATW
$717M
$18.5K ﹤0.01%
667
+366
+122% +$9.38K
HYLS icon
2005
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.63B
$18.4K ﹤0.01%
446
-139
-24% -$5.8K
CMRE icon
2006
Costamare
CMRE
$1.74B
$18.4K ﹤0.01%
1,434
-20
-1% -$275
CALX icon
2007
Calix
CALX
$2.4B
$18.4K ﹤0.01%
528
-140
-21% -$4.93K
PTGX icon
2008
Protagonist Therapeutics
PTGX
$9.71B
$18.3K ﹤0.01%
475
-77
-14% -$3.36K
BOOM icon
2009
DMC Global
BOOM
$153M
$18.2K ﹤0.01%
2,478
+2,464
+17,600% +$23.2K
OPCH icon
2010
Option Care Health
OPCH
$3.67B
$18.2K ﹤0.01%
784
-113
-13% -$2.86K
SPCE icon
2011
Virgin Galactic
SPCE
$415M
$18.2K ﹤0.01%
3,087
+3,036
+5,953% +$20.2K
WNS
2012
DELISTED
WNS Holdings
WNS
$18.1K ﹤0.01%
382
-1,759
-82% -$86.8K
HHH icon
2013
Howard Hughes
HHH
$3.91B
$18.1K ﹤0.01%
235
+77
+49% +$6.13K
MMI icon
2014
Marcus & Millichap
MMI
$1.16B
$18.1K ﹤0.01%
472
-141
-23% -$5.53K
AGNC icon
2015
AGNC Investment
AGNC
$12.8B
$18.1K ﹤0.01%
1,960
+613
+46% +$5.98K
BXMT icon
2016
Blackstone Mortgage Trust
BXMT
$2.39B
$18K ﹤0.01%
1,035
-191
-16% -$3.53K
ARR
2017
Armour Residential REIT
ARR
$2.34B
$18K ﹤0.01%
954
+107
+13% +$2.05K
OMF icon
2018
OneMain Financial
OMF
$7.27B
$18K ﹤0.01%
345
+19
+6% +$985
AROW icon
2019
Arrow Financial
AROW
$644M
$18K ﹤0.01%
626
+23
+4% +$701
KUB
2020
DELISTED
KUBOTA CORPORATION (ONE ADS REP 5 SHS COM)
KUB
$17.9K ﹤0.01%
310
-45
-13% -$2.6K
REXR icon
2021
Rexford Industrial Realty
REXR
$8.13B
$17.9K ﹤0.01%
463
-1,387
-75% -$59.6K
GCMG icon
2022
GCM Grosvenor
GCMG
$834M
$17.9K ﹤0.01%
1,455
+466
+47% +$5.54K
COWZ icon
2023
Pacer US Cash Cows 100 ETF
COWZ
$19.6B
$17.8K ﹤0.01%
316
RARE icon
2024
Ultragenyx Pharmaceutical
RARE
$2.64B
$17.8K ﹤0.01%
424
+29
+7% +$1.44K
EMBJ
2025
Embraer S.A. ADS
EMBJ
$13.1B
$17.8K ﹤0.01%
486
+63
+15% +$2.27K

Similar funds

GAMMA Investing's Q4 2024 Portfolio in Review

As of Q4 2024, GAMMA Investing held 3,876 positions worth $1.17B, up 16% from $1.01B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

GAMMA Investing deployed $157M of net new capital in Q4 2024, opening 301 new positions and adding to 2,412 existing holdings. Its largest new stake was iShares China Large-Cap ETF: 7,320 shares worth $223K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.01M trimmed.

  • GAMMA Investing's largest Q4 2024 buy was iShares China Large-Cap ETF: 7,320 shares worth $223K.
  • GAMMA Investing added most to Apple in Q4 2024, an estimated $7.19M increase.
  • GAMMA Investing's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $1.01M.
  • GAMMA Investing fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $634K.
  • GAMMA Investing's ten largest holdings make up 26% of its $1.17B portfolio in Q4 2024.
  • GAMMA Investing opened 301 new positions and closed 99 in Q4 2024.
  • GAMMA Investing's portfolio value rose 16% quarter-over-quarter to $1.17B.

Based on GAMMA Investing's 13F filing for Q4 2024, filed 3 Jan 2025.